Renal cell carcinoma rarely announces itself. More than 60% of cases are discovered incidentally on abdominal imaging ordered for unrelated reasons, and the classic triad of flank pain, hematuria, and a palpable mass now occurs in fewer than 10% of patients. That shift in how the disease presents makes appropriate follow-up of incidental renal findings one of the most consequential actions in primary care. Five-year survival is 93% for localized disease and 17 to 18% for distant disease. With approximately 81,000 new diagnoses expected annually and nearly half occurring in adults 65 and older, the stakes of appropriate surveillance are substantial.
AAVBC's Renal Cancer Quick Reference Guide gives primary care clinicians a structured reference for managing RCC from incidental detection through long-term follow-up. It covers histologic subtype recognition, laterality-specific ICD-10 coding, renal pelvis versus parenchymal tumor distinctions, metastatic site documentation, modifiable risk factor management, and MEAT documentation standards — grounded in current NCCN and AUA guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of renal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Renal cell carcinoma rarely announces itself. More than 60% of cases are discovered incidentally on abdominal imaging ordered for unrelated reasons, and the classic triad of flank pain, hematuria, and a palpable mass now occurs in fewer than 10% of patients. That shift in how the disease presents makes appropriate follow-up of incidental renal findings one of the most consequential actions in primary care. Five-year survival is 93% for localized disease and 17 to 18% for distant disease. With approximately 81,000 new diagnoses expected annually and nearly half occurring in adults 65 and older, the stakes of appropriate surveillance are substantial.
AAVBC's Renal Cancer Quick Reference Guide gives primary care clinicians a structured reference for managing RCC from incidental detection through long-term follow-up. It covers histologic subtype recognition, laterality-specific ICD-10 coding, renal pelvis versus parenchymal tumor distinctions, metastatic site documentation, modifiable risk factor management, and MEAT documentation standards — grounded in current NCCN and AUA guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of renal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
